Europe alerts of more bloodstream infections caused by antibiotic-resistant K. pneumoniae and E. coli

The ECDC warns of the sharp increase in bloodstream infections caused by multidrug-resistant bacteria in Europe and the slow progress in reducing the use of antibiotics.

3 minutes

Add DEMÓCRATA to Google

Published

3 minutes

Bloodstream infections caused by carbapenem-resistant "Klebsiella pneumoniae" have grown by 72 percent, while cases due to third-generation cephalosporin-resistant "Escherichia coli" have increased by 16.4 percent in 2025 in Europe, compared with figures from 2019.

These data come from the latest report on antimicrobial resistance from the European Centre for Disease Prevention and Control (ECDC, for its acronym in English), released this Wednesday, coinciding with the European Day for Prudent Use of Antibiotics.

The document draws attention to the upturn in infections caused by resistant bacteria and especially highlights "K. pneumoniae" and "E. coli" for their rapid spread in hospitals and other care settings, their potential to cause severe illness and their high resistance to most available antibiotics.

The ECDC warns that, for now, many of the commitments set for 2030 are far from being met, since infections by carbapenem-resistant "K. pneumoniae" would have to decrease by five percent and those associated with "E. coli" by 10 percent.

Instead, another of the monitored bacteria, methicillin-resistant "Staphylococcus aureus" (MRSA), is moving in the direction expected, after recording a 19 percent drop in its incidence in bloodstream infections. However, the report уточняет that the increases observed in the past two years put this progress at risk.

Antibiotic consumption: insufficient progress

In parallel, the ECDC has released another analysis on antibiotic use that concludes that the use of these drugs does not decline at the desired pace. Between 2019 and 2025 only a five percent reduction was achieved, far from the 20 percent cut target set for 2030.

By contrast, the proportion of first-line antibiotics included in the World Health Organization’s (WHO) list rose from 61.1 to 62.5 percent, approaching the 65 percent target.

The European body recalls that 90 percent of antibiotic use in humans is concentrated in the community or outpatient care. For this reason, this year’s campaign puts the emphasis on children, one of the groups most exposed to these medications.

Under the slogan "Take care of your children: use antibiotics with prudence", the initiative insists to parents and caregivers that many common childhood conditions, such as colds, coughs, or sore throat, have a viral origin and do not require antibiotics, and that these should only be used when prescribed by a healthcare professional and are medically necessary.

"We are still lagging behind several of the EU’s 2030 targets in the fight against antimicrobial resistance. However, the good news is that now we can go further than the numbers", said ECDC Director Pamela Rendi-Wagner.

In this vein, she has highlighted the role of innovative tools such as genomic surveillance in evaluation, which make it easier to intervene earlier to curb transmission, guide treatment decisions more effectively, and identify in which areas new antibiotics are most urgently needed.

Call for rapid and sustained action

The ECDC calls on Member States to adopt urgent and sustained measures in infection prevention and control, responsible use of antimicrobials, strengthening laboratory capacity, and improved surveillance systems.

At the point of care, priorities include rigorous hand hygiene, appropriate use of personal protective equipment, early detection and isolation of cases, and effective environmental cleaning and disinfection.

In addition, the agency emphasizes that those responsible for health management and health systems must support these strategies by providing sufficient specialized personnel for infection control, access to adequate laboratory diagnostics, isolation beds, surveillance systems, training programs, and coordination mechanisms between centers and regions.